The FDA has approved RiaSTAP(purified fibrinogen concentrate, from CSL Behring) for the treatment of acutebleeding episodes in patients with congenital fibrinogen deficiency, includingafibrinogenemia ...
WASHINGTON, Jan. 20 (UPI) -- The U.S. Food and Drug Administration has approved RiaSTAP for the treatment of bleeding in patients with a rare genetic defect. People with the defect -- congenital ...
Jan. 17 -- FRIDAY, Jan. 16 (HealthDay News) -- The U.S. Food and Drug Administration has approved Riastap to treat a blood disorder caused by a rare genetic condition. The disorder, congenital ...
ROCKVILLE, Md., Jan 9 (Reuters) - CSL Ltd's experimental treatment for patients with an extremely rare bleeding disorder won unanimous support from a U.S. advisory panel on Friday, which said it was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results